China Biologic Products Holdings سهم وتحليل الأسهم
China Biologic Products Holdings Inc. is a Chinese pharmaceutical company that specializes in the development, production, and marketing of biological products since its establishment in 1971. The company is headquartered in Beijing and is listed on the Nasdaq.
History
China Biologic Products Holdings Inc. was founded in 1971 and immediately began producing blood plasma products. Over the following decades, the company expanded significantly and established itself as a leading manufacturer of blood plasma products in China. In 2007, China Biologic Products Holdings Inc. was listed on the Nasdaq, where it is still active today.
Business Model
China Biologic Products Holdings Inc. specializes in the production and marketing of biological products. This includes a wide range of products such as blood plasma products, human albumin, immunoglobulins, and vaccines. The company is also involved in the development of new products and technologies and works closely with leading researchers and scientists to offer its customers the latest and most innovative products.
Segments and Products
China Biologic Products Holdings Inc. is divided into several segments to organize its various product lines. The main segments are plasma products, albumin, immunoglobulins, and vaccines.
The plasma products segment is the largest and most well-known segment of the company and includes a wide range of blood plasma products such as factor VIII, factor IX, prothrombin complex concentrates, and albumin. These products are primarily used for the treatment of blood disorders and other medical conditions.
The albumin segment produces human albumin, which can be used to treat a wide range of diseases, including cardiovascular diseases, liver diseases, and burns.
The immunoglobulin segment produces antibody-rich immunoglobulins for the treatment of various autoimmune diseases and immune disorders, as well as for use in immunotherapy.
The vaccine segment is responsible for the production of a variety of vaccines, including DTP vaccines, hepatitis B vaccines, HPV vaccines, and other important vaccines for the prevention of infectious diseases.
Summary
China Biologic Products Holdings Inc. is a leading pharmaceutical company in China that specializes in the production and marketing of biological products. The company produces a wide range of products, including blood plasma products, human albumin, immunoglobulins, and vaccines. China Biologic Products Holdings Inc. has experienced significant growth over the past few decades and is now a key player in the global market for biological products. China Biologic Products Holdings هو أحد الشركات الأكثر شعبية على Eulerpool.com.
